Drug intelligence / Profile preview

CALPXT96

Development stage: Discontinued
Lead developer: Lumiera Health Innovation
Administration: Oral

Overview

CALPXT96 is a patented, plant-based ingredient derived primarily from California poppy and used as a co-analgesic and sleep aid. It is formulated to improve sleep quality and provide additional analgesia for patients with chronic non-cancer pain. Unlike many conventional hypnotics, CALPXT96 aims to avoid adverse effects such as dependency or increased risk of apnea when combined with opioids. The ingredient is featured in the Bazzzics product line, which combines several herbal extracts (California poppy, lemon balm, passionflower, skullcap) traditionally used for their sedative and anxiolytic properties. Clinical trials have been conducted to assess its efficacy in improving sleep quality in patients with chronic pain[1][2][4][5].

Brand names: Bazzzics

Beyond the preview

Go deeper on CALPXT96.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CALPXT96.

Explore the full profile